The decrease in the circulating levels of MCP-1 in patients with CLD may be attributed to its increased utilization or its temporal expression and secretion in sites of inflammations which may suggest that MCP-1 is predominantly locally produced within the liver. Here, CCL2 is linked to congenital secretory chloride diarrhea 1.